Quick Answer
Lifevantage Corp reported Research And Development Expense of $2.95 million for the year ending 2013.
- Lifevantage Corp showed an increase of +116.9% in Research And Development Expense from 2012 to 2013.
- This data is from Lifevantage Corp's annual report (Form 10-K), filed with the SEC on September 12, 2013.
- XBRL data for this metric is available from 2011 to 2013 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2010: $89.7 thousand | Q1 2011: $115.5 thousand | Q3 2011: $234.0 thousand | Q4 2011: $312.0 thousand | Q1 2012: $378.0 thousand | Q3 2012: $514.0 thousand | Q4 2012: $742.0 thousand | Q1 2013: $848.0 thousand | Q3 2013: $307.0 thousand | Q4 2013: $584.0 thousand | Q1 2014: $655.0 thousand.
- Over the full 3 years of available data (2011 to 2013), Lifevantage Corp's Research And Development Expense has grown by 479.2%.
- Historical annual values: Fiscal year 2013: $2.95 million | Fiscal year 2012: $1.36 million | Fiscal year 2011: $509.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: